DalsnaFinance

ProBio and GCP ClinPlus Partner to Accelerate Clinical Trials in China

Markets PR Newswire By PR Newswire 03 Jun 2026 13:23 1 min read
ProBio and GCP ClinPlus Partner to Accelerate Clinical Trials in China

ProBio and GCP ClinPlus today announced a strategic collaboration designed to accelerate Investigator-Initiated Trials (IITs) in China and provide integrated, end-to-end clinical and development solutions for global biopharma customers. HOPEWELL, N.J., June 3, 2026 /PRNewswire/ -- As...

ProBio and GCP ClinPlus today announced a strategic collaboration designed to accelerate Investigator-Initiated Trials (IITs) in China and provide integrated, end-to-end clinical and development solutions for global biopharma customers. HOPEWELL, N.J., June 3, 2026 /PRNewswire/ -- As...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.